Search results

Evidence-based recommendations on transvaginal laser therapy for urinary stress incontinence. This involves using a laser in the vagina to strengthen the

Type

Interventional procedures guidance

Published

26 May 2021

Evidence-based recommendations on transvaginal laser therapy for urogenital atrophy. This involves using a laser in the vagina to increase its strength and

Type

Interventional procedures guidance

Published

26 May 2021

Evidence-based recommendations on electrohydraulic lithotripsy for difficult-to-treat bile duct stones in adults. This involves breaking up the stone with sound

Type

Interventional procedures guidance

Published

26 May 2021

Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography

Type

Medical technologies guidance

Last updated

19 May 2021

Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers

Type

Medical technologies guidance

Last updated

19 May 2021

Evidence-based recommendations on ofatumumab (Kesimpta) for treating relapsing–remitting multiple sclerosis in adults with active disease defined by clinical or

Type

Technology appraisal guidance

Published

19 May 2021

NICE is unable to make a recommendation on selinexor with low-dose dexamethasone for treating refractory multiple myeloma in adults because Karyopharm

Type

Technology appraisal guidance

Published

19 May 2021

NICE is unable to make a recommendation on crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older because Pfizer withdrew its

Type

Technology appraisal guidance

Published

19 May 2021

Evidence-based recommendations on ravulizumab (Ultomiris) for treating paroxysmal nocturnal haemoglobinuria in adults

Type

Technology appraisal guidance

Published

19 May 2021

Evidence-based recommendations on tafamidis (Vyndaqel) for treating transthyretin amyloidosis with cardiomyopathy in adults

Type

Technology appraisal guidance

Published

12 May 2021

Evidence-based recommendations on andexanet alfa (Ondexxya) for reversing anticoagulation form apixaban or rivaroxaban in adults with life-threatening or

Type

Technology appraisal guidance

Published

12 May 2021

Evidence-based recommendations on permanent His-bundle pacemaker implantation for treating heart failure. This involves attaching a wire to the heart’s

Type

Interventional procedures guidance

Published

05 May 2021

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

Type

Medical technologies guidance

Published

04 May 2021

Evidence-based recommendations on pembrolizumab (Keytruda) for treating locally advanced or metastatic urothelial carcinoma after platinum

Type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on olaparib (Lynparza) plus bevacizumab (Avastin) for maintenance treatment of advanced ovarian, fallopian tube or primary perito

Type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on carfilzomib (Kyprolis) with dexamethasone and lenalidomide (Revlimid) for previously treated multiple myeloma in adults

Type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on short-pulse transscleral cyclophotocoagulation for glaucoma. This involves using repeated short pulses of laser energy to

Type

Interventional procedures guidance

Published

28 April 2021

Evidence-based recommendations on deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults. This involves implant

Type

Interventional procedures guidance

Published

28 April 2021

Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an

Type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on avelumab (Bavencio) for untreated metastatic Merkel cell carcinoma in adults

Type

Technology appraisal guidance

Published

21 April 2021

Evidence-based recommendations on acalabrutinib (Calquence) for treating chronic lymphocytic leukaemia in adults

Type

Technology appraisal guidance

Published

21 April 2021

NICE is unable to make a recommendation on teduglutide (Revestive) for short bowel syndrome in people 1 year and over because Takeda withdrew its evidence

Type

Technology appraisal guidance

Published

21 April 2021

Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic canc

Type

Interventional procedures guidance

Published

21 April 2021

Evidence-based recommendations on avelumab (Bavencio) for metastatic Merkel cell carcinoma in adults

Type

Technology appraisal guidance

Last updated

21 April 2021

Evidence-based recommendations on Danis stent for acute oesophageal variceal bleeding

Type

Medical technologies guidance

Published

31 March 2021

Evidence-based recommendations on anakinra (Kineret) for treating adult-onset Still’s disease and systemic juvenile idiopathic arthritis in people 8 months and

Type

Technology appraisal guidance

Published

31 March 2021

NICE is unable to make a recommendation on blinatumomab (Blincyto) for previously treated Philadelphia-chromosome-positive acute lymphoblastic leukaemia in

Type

Technology appraisal guidance

Published

31 March 2021

Evidence-based recommendations on ribociclib (Kisqali) for treating hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally

Type

Technology appraisal guidance

Published

31 March 2021

Evidence-based recommendations on selective internal radiation therapies SIR-Spheres (Sirtex), TheraSphere (BTG) and QuiremSphere (Quirem Medical) for treating

Type

Technology appraisal guidance

Published

31 March 2021

Evidence-based recommendations on transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids in adults. This involves inserting a

Type

Interventional procedures guidance

Published

31 March 2021

Evidence-based recommendations on extracorporeal whole liver perfusion for acute liver failure

Type

Interventional procedures guidance

Published

31 March 2021

Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography

Type

Diagnostics guidance

Published

17 March 2021

Evidence-based recommendations on nivolumab (Opdivo) for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease in

Type

Technology appraisal guidance

Published

17 March 2021

Evidence-based recommendations on erenumab (Aimovig) for preventing migraine in adults

Type

Technology appraisal guidance

Published

10 March 2021

Evidence-based recommendations on pembrolizumab (Keytruda) with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung

Type

Technology appraisal guidance

Published

10 March 2021

Evidence-based recommendations on Alpha-Stim AID for anxiety disorders

Type

Medical technologies guidance

Published

08 March 2021

Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple

Type

Technology appraisal guidance

Published

03 March 2021

Evidence-based recommendations on baricitinib for treating moderate to severe atopic dermatitis in adults

Type

Technology appraisal guidance

Published

03 March 2021

Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves

Type

Interventional procedures guidance

Published

03 March 2021

Evidence-based recommendations on free-functioning gracilis transfer to restore upper limb function in brachial plexus injury in adults. This involves a piece o

Type

Interventional procedures guidance

Published

03 March 2021

This guideline covers keeping adults in care homes safe from abuse and neglect. It includes potential indicators of abuse and neglect by individuals or organisations, and covers the safeguarding process from when a concern is first identified through to section 42 safeguarding enquiries. There are recommendations on policy, training, and care home culture, to improve care home staff awareness of safeguarding and ensure people can report concerns when needed.

Type

NICE guideline

Published

26 February 2021

Evidence-based recommendations on filgotinib (Jyseleca) for moderate to severe rheumatoid arthritis in adults

Type

Technology appraisal guidance

Published

24 February 2021

Evidence-based recommendations on autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma in adults who have

Type

Technology appraisal guidance

Published

24 February 2021

NICE is unable to make a recommendation on omalizumab (Xolair) for treating chronic rhinosinusitis with nasal polyps in adults because Novartis Pharmaceuticals

Type

Technology appraisal guidance

Published

24 February 2021

Evidence-based recommendations on dapagliflozin (Forxiga) for symptomatic chronic heart failure with reduced ejection fraction in adults

Type

Technology appraisal guidance

Published

24 February 2021

Evidence-based recommendations on niraparib for maintenance treatment of advanced (FIGO stages 3 and 4) high-grade epithelial ovarian, fallopian tube or primary

Type

Technology appraisal guidance

Published

17 February 2021

NICE is unable to make a recommendation on pembrolizumab (Keytruda) for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when

Type

Technology appraisal guidance

Published

17 February 2021

NICE is unable to make a recommendation on vernakalant (Brinavess) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. This

Type

Technology appraisal guidance

Published

17 February 2021

Evidence-based recommendations on trabectedin (Yondelis) for treating advanced soft tissue sarcoma (tumours/cancer)

Type

Technology appraisal guidance

Last updated

08 February 2021

Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery

Type

Medical technologies guidance

Published

03 February 2021